Drug Type Small molecule drug |
Synonyms Kenbran Powder, Methacholine chloride (JAN/USP/INN), Provocholine Powder + [10] |
Target |
Mechanism mAChRs agonists(Muscarinic acetylcholine receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date US (31 Oct 1986), |
Regulation- |
Molecular FormulaC8H18ClNO2 |
InChIKeyJHPHVAVFUYTVCL-UHFFFAOYSA-M |
CAS Registry62-51-1 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D04970 | Methacholine Chloride |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Diagnostic agents | JP | 22 Jan 2016 | |
Respiratory Hypersensitivity | JP | 22 Jan 2016 | |
Respiratory Hypersensitivity | JP | 22 Jan 2016 | |
Asthma | US | 31 Oct 1986 |
Not Applicable | 7 | Computed Tomography imaging, functional Positron Emission Tomography imaging+Nebulized methacholine inhalation | rxjfwbpsjh(qqbvkdslru) = eequnnckps qafnapqgyd (bqricglmek, nvockewoef - xmmceekenx) View more | - | 25 Apr 2017 | ||
Phase 3 | 10 | bpqwhvgquz(kijdhhjsij) = hdpnkbjegw rzsigxlvty (xyxtpdhitu, zlnpgqgntp - wiesyvhrfk) View more | - | 14 Feb 2017 |